OverviewChartTechnicalNewsTraderScreen

vTv Therapeutics Inc/  US9183852048  /

NASDAQ
2024-04-25  5:41:12 PM Chg. -0.0100 Volume Bid2024-04-25 Ask2024-04-25 High Low
25.4900USD -0.04% 453
Turnover: 2,549		 24.0800Bid Size: 100 25.5000Ask Size: 200 25.4900 25.4900
GlobeNewswire 03-13 vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporat...
GlobeNewswire 03-04 vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with ...
GlobeNewswire 03-01 vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire 02-28 vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Inves...
GlobeNewswire 02-21 AdhereTech Announces Appointment of Paul Sekhri to Board of Directors
GlobeNewswire 2023-11-13 Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-09 vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-08 vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
GlobeNewswire 2023-11-02 vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
GlobeNewswire 2023-11-01 vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 Million
GlobeNewswire 2022-03-23 Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busin...
GlobeNewswire 2022-01-13 vTv Therapeutics Shares Updated Corporate Presentation
GlobeNewswire 2021-12-06 vTv Therapeutics Announces Restructuring to Prioritize its Lead Program and Focus Operations
GlobeNewswire 2021-11-09 vTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire 2021-10-12 vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of K...
GlobeNewswire 2021-10-06 Lottery.com Announces Nominees to the Post-Closing Board of Directors
GlobeNewswire 2021-09-23 vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737,...
GlobeNewswire 2021-08-04 vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update
GlobeNewswire 2021-06-29 vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Pos...
GlobeNewswire 2021-06-22 vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development a...
GlobeNewswire 2021-05-05 vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire 2021-04-13 vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type ...
GlobeNewswire 2021-04-12 TTP399 SimpliciT-1 Study Results to be presented at a scientific symposium in celebration of the 100...
GlobeNewswire 2021-03-23 vTv Therapeutics Announces Issuance of U.S. Patent Covering Methods of Treatment Using TTP399
GlobeNewswire 2021-03-18 vTv Therapeutics Announces Initiation of Study Evaluating TTP399’s Potential to Reduce Risk of Diabe...